Pzena Investment Management LLC Buys 42,184 Shares of Amdocs Limited $DOX

Pzena Investment Management LLC increased its stake in Amdocs Limited (NASDAQ:DOX) by 0.6% in the third quarter, HoldingsChannel reports. The fund owned 6,593,249 shares of the technology company’s stock after purchasing an additional 42,184 shares during the period. Amdocs makes up about 1.8% of Pzena Investment Management LLC’s portfolio, making the stock its 22nd biggest position. Pzena Investment Management LLC owned about 0.06% of Amdocs worth $540,976,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. MJP Associates Inc. ADV lifted its position in Amdocs by 5.4% in the third quarter. MJP Associates Inc. ADV now owns 7,983 shares of the technology company’s stock valued at $655,000 after purchasing an additional 406 shares during the last quarter. Martin & Co. Inc. TN increased its stake in shares of Amdocs by 0.5% in the third quarter. Martin & Co. Inc. TN now owns 65,048 shares of the technology company’s stock worth $5,337,000 after buying an additional 302 shares during the period. Vanguard Group Inc. increased its stake in shares of Amdocs by 0.3% in the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after buying an additional 9,207 shares during the period. Todd Asset Management LLC raised its holdings in Amdocs by 5.4% during the 3rd quarter. Todd Asset Management LLC now owns 491,197 shares of the technology company’s stock valued at $40,303,000 after buying an additional 25,362 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in Amdocs by 41.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 376,039 shares of the technology company’s stock valued at $30,854,000 after buying an additional 109,915 shares during the period. 92.02% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Barclays lowered their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Stifel Nicolaus reduced their target price on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Amdocs has a consensus rating of “Moderate Buy” and an average target price of $92.33.

Amdocs Stock Up 3.1%

Shares of NASDAQ:DOX opened at $70.56 on Thursday. The firm has a market capitalization of $7.62 billion, a P/E ratio of 13.65, a P/E/G ratio of 1.22 and a beta of 0.40. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.17 and a current ratio of 1.06. The stock has a 50 day moving average price of $79.15 and a 200-day moving average price of $81.41. Amdocs Limited has a 52-week low of $66.53 and a 52-week high of $95.41.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.06. The company had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, equities research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be given a dividend of $0.569 per share. This is an increase from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a yield of 3.2%. Amdocs’s dividend payout ratio is 40.81%.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.